Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01125215

Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy

Study of Topical Preparation of Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy

Sponsor: Mahidol University

Interventions 0.75% capsaicin nanoparticle cream Placebo

Updated 6 times since 2017 Last updated: Apr 10, 2013 Started: Sep 30, 2009 Primary completion: Oct 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01125215, this PHASE2/PHASE3 trial focuses on Painful Diabetic Neuropathy and remains ongoing. Sponsored by Mahidol University, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mahidol University
Thailand Research Fund

Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand
• Pathum Thani, Thailand